The FDA approved 3 new color additives, a move that will provide manufacturers with a wider range of natural color options to safely be used in food.

A Cornell University project to save babies born with serious heart defects has lost key funding just days after it was approved.

Topline results were announced from a phase 3 study comparing aficamten with metoprolol in adults with symptomatic obstructive hypertrophic cardiomyopathy.

High cardiovascular health was associated with a reduced effect of insulin resistance on all-cause and cardiovascular mortality risk.

The FDA has approved HemiClor (12.5 mg chlorthalidone) tablets for the treatment of hypertension in adults, to lower blood pressure.